MIM
GWPH

Meridiem Investment Management’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

Meridiem Investment Management’s Portfolio GWPH Stock Details GWPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-1,500
Closed -$325K – 78
2021
Q1 		$325K Buy
+1,500
New +$282K 0.01% 44

Other funds holding GWPH

HDIM
Hanson & Doremus Investment Management Burlington, Vermont $983M AUM 34.23% 1-Year Est. Return

Meridiem Investment Management's GWPH Position: Q2 2021 in Review

Meridiem Investment Management sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q2 2021, closing a stake of 1,500 shares — an estimated $325K sold.

Meridiem Investment Management first reported a position in GWPH in Q1 2021 and held it in 1 quarter. The position peaked at $325K in Q1 2021. 1 fund tracked by Wall St. Rank holds GWPH as of Q2 2021.

  • Meridiem Investment Management reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q2 2021 after selling out during the quarter.
  • Meridiem Investment Management sold 1,500 GW Pharmaceuticals Plc American Depositary Shares shares in Q2 2021, an estimated $325K.
  • Meridiem Investment Management first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q1 2021 and held it in 1 quarter.
  • Meridiem Investment Management's GW Pharmaceuticals Plc American Depositary Shares position peaked at $325K in Q1 2021.
  • 1 fund tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q2 2021.

Based on Meridiem Investment Management's 13F filing for Q2 2021, filed 5 Aug 2021.